Corporate Publications

Grünenthal is a global leader in pain management and related diseases. As a science-based, fully-integrated pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our purpose is to change lives for the better – and innovation is our passion. We are focusing all of our activities and efforts on working towards our vision of a world free of pain.

Grünenthal is a global company headquartered in Aachen, Germany, and has affiliates in 27 countries across Europe, Latin America, and the U.S. Patients and customers benefit from Grunenthal products in around 100 countries worldwide. In 2023 Grünenthal employed around 4,400 people and achieved revenues of €1.8 bn.